Healthcare Deals and Investments
Healthcare Deals and Investments
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Avalyn Pharma, a biotech developing inhaled formulations of approved pulmonary fibrosis drugs, announced it has filed for an initial public offering. The company aims to raise capital to fund its late-stage development work and bring its treatments to market.
Swiss biotech Basilea Pharmaceutica announced it has received an additional US$6 million non‑dilutive grant from the non‑profit accelerator CARB‑X to fund the Phase I trial of its novel Gram‑negative antibiotic BAL2420. The funding follows six years of CARB‑X support and enables the...
Private equity firm GTCR has completed its acquisition of European generics pharmaceutical company Zentiva, buying it from Advent. The deal was announced on April 9, 2026, marking GTCR's entry into the generics market. Deal value was not disclosed.
Gilead has entered into a definitive agreement to acquire Tubulis, an ADC research organization, for an upfront $3.15B plus up to $1.85B in contingent milestone payments, totaling roughly $5B. The acquisition will expand Gilead’s ADC capabilities and add next‑generation assets...
ReAlta Life Sciences Inc., a clinical-stage biopharma focused on neutrophil and complement system therapies, announced the closing of an oversubscribed $40 million financing, bringing its total capital raised to over $150 million. The round was completed on April 8, 2026, marking a significant funding...
Max Healthcare has entered a share purchase agreement to acquire a 58.4% controlling stake in Kalinga Hospital Limited from Hospital Corporation of Orissa for an equity value of $36.6M. The deal expands Max's footprint in eastern India, adding a 250‑bed...
San Francisco‑based AI healthcare startup Health Universe announced it has closed a $6 million seed round led by Kleiner Perkins. The funding will support the company’s AI sandbox platform that enables healthcare organizations to build and deploy AI agents securely. The...
E2, a commercial-stage medical technology firm, closed an $80 million Series C round led by Gilde Healthcare and Norwest, with participation from existing investors Santé Ventures, 415 Capital, S3 Ventures, Panakès Partners and M&L Healthcare Investments. The funding will accelerate commercialization of...
Data services firm ESO Solutions, Inc. announced the acquisition of healthcare performance improvement company d2i. The deal, terms undisclosed, will enable ESO to create an unbroken data pipeline from 911 dispatch through post‑acute hospital care, leveraging d2i’s analytics platform that...
Empath Health has completed the integration of hospice provider Trustbridge, finalizing a two‑year affiliation and effectively acquiring the organization. The combined entity will operate under the Empath Trustbridge Hospice brand, with a focus on expanding dementia care services in 2026.
Ekuiti Nasional Bhd (Ekuinas) announced a strategic investment through its RM1 billion Tranche IV fund, acquiring a minority stake in Ain Medicare Sdn Bhd, a Bumiputera-owned sterile parenteral pharmaceutical manufacturer. The deal supports Ekuinas' mandate to grow Bumiputera enterprises in strategic sectors...
Boston Scientific has closed its acquisition of incontinence device maker Valencia Technologies, gaining control of the eCoin tibial nerve stimulator. The deal, first announced in January, positions Boston Scientific to compete with Medtronic in the urinary incontinence market. Valencia is...
South Korean medical AI startup Mediwhale raised 20 billion won ($13 million) in a Series C round led by Premier Partners, with participation from KB Investment, Quad Asset Management, IMM Investment, Hana Ventures, AON Investment and Startup Partners. The capital will fund clinical...
Ambient Clinical Analytics announced the closing of a $5 million strategic funding round led by Mairs & Power Venture Capital and an unnamed Fortune 500 MedTech firm. The capital will accelerate innovation and expand adoption of its FDA Class II‑cleared...
Hospice News’ parent company WTWH Media announced the acquisition of HealthLeaders, a media and events platform for hospital and health‑system executives. The deal expands WTWH’s healthcare portfolio and enhances its ability to connect decision‑makers across the care continuum.
